| S1773 |
Oxytetracycline (Terramycin)
|
Oxytetracycline (Terramycin) is a broad-spectrum tetracycline antibiotic used to treat infections with bacteria.
|
-
Sci Rep, 2018, 8(1):7653
-
Front Microbiol, 2016, 7: 1765
|
|
| S7417 |
Puromycin Dihydrochloride
|
Puromycin 2HCl is an aminonucleoside antibiotic derived from Streptomyces alboniger. It is an inhibitor of protein synthesis and has been used to study transcription regulatory mechanisms that control the sequential and coordinated expression of genes during cell differentiation.
|
-
Signal Transduct Target Ther, 2025, 10(1):182
-
Cell Stem Cell, 2025, S1934-5909(25)00181-X
-
Nat Commun, 2025, 16(1):4792
|
|
| S5159 |
Doxycycline
|
Doxycycline (Vibramycin, Doxytetracycline, Doxiciclina, Doxycyclinum) is an antibiotic that is used in the treatment of a number of types of infections caused by bacteria and protozoa. Doxycycline is also a nonspecific matrix metalloproteinase (MMP) inhibitor.
|
-
Nature, 2025, 10.1038/s41586-025-09222-5
-
Cell Stem Cell, 2025, S1934-5909(25)00181-X
-
Nat Commun, 2025, 16(1):7898
|
|
| S4163 |
Doxycycline Hyclate
|
Doxycycline Hyclate is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. It is also an inhibitor of matrix metallo-proteinases (MMP).
|
-
Cell Discov, 2025, 11(1):41
-
Adv Sci (Weinh), 2025, 12(41):e03977
-
Dev Cell, 2025, S1534-5807(25)00405-8
|
|
| S1403 |
Tigecycline
|
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. This compound induces autophagy by downregulating the PI3K-AKT-mTOR pathway.
|
-
J Infect Dis, 2025, 232(3):e416-e420
-
NPJ Antimicrob Resist, 2025, 3(1):12
-
Int J Mol Sci, 2024, 25(9)4887
|
|
| S2908 |
Hygromycin B
|
Hygromycin B (Hygrovetine), a selective antibiotic that is effective on most bacteria, fungi and higher eukaryotes, inhibits protein synthesis by interfering with translocation and causing mistranslation at the 70S ribosome.
|
-
Nat Commun, 2024, 15(1):10594
-
Redox Biol, 2024, 76:103349
-
Front Pharmacol, 2024, 15:1432851
|
|
| S2572 |
Streptomycin sulfate
|
Streptomycin sulfate(Phytomycin) is a sulfate salt of streptomycin that is a protein synthesis inhibitor.
|
-
Front. Oncol, 2023-, Volume 13
-
Front Oncol, 2023, 13:1118268
-
Transl Oncol, 2022, 26:101502
|
|
| S2555 |
Clarithromycin
|
Clarithromycin (A-56268) is a macrolide antibiotic and a CYP3A4 inhibitor, used to treat a number of bacterial infections.
|
-
Circulation, 2024, 150(7):563-576
-
Microorganisms, 2022, 10(7)1421
-
Cell Biol Toxicol, 2021, 10.1007/s10565-021-09646-5
|
|
| S2574 |
Tetracycline HCl
|
Tetracycline HCl (NCI-c55561) is a hydrochloride salt of tetracycline that is a broad-spectrum polyketide antibiotic.
|
-
Nat Commun, 2024, 15(1):2377
-
Antiviral Res, 2020, 185:104993
-
PLoS Pathog, 2020, 16;16(3):e1008341
|
|
| S1635 |
Erythromycin
|
Erythromycin (E-Mycin) is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin (IC50=1.5 μg/ml).
|
-
Autophagy, 2025, 1-17.
-
Infect Drug Resist, 2023, 16:4867-4879
-
J Med Chem, 2018, 61(9):4189-4202
|
|
| S1677 |
Chloramphenicol
|
Chloramphenicol (Chloromycetin) is a bacteriostatic by inhibiting protein synthesis.
|
-
Cell Rep, 2021, 34(3):108631
-
EMBO Rep, 2021, e53081
-
Oncotarget, 2018, 9(40):26086-26095
|
|
| S4490 |
Tetracycline
|
Tetracycline (TC) is a broad-spectrum antibiotic that exhibits activity against a wide range of microorganisms including gram-positive and gram-negative bacteria, chlamydiae, mycoplasmas, rickettsiae, and protozoan parasites.
|
-
Redox Biol, 2025, 84:103649
-
bioRxiv, 2025, 2025.01.08.632009
-
PeerJ, 2022, 10:e13719
|
|
| S2315 |
Kanamycin sulfate
|
Kanamycin sulfate (Kanamycin monosulfate, Ophtalmokalixan) is an aminoglycoside antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections.
|
-
Heliyon, 2024, 10(11):e32571
-
Oncotarget, 2018, 9(40):26086-26095
|
|
| S2510 |
Spectinomycin 2HCl
|
Spectinomycin 2HCl (Actinospectacin) is a new parenteral antibiotic prepared from Streptomyces spectabilis.
|
-
Cell Rep, 2020, 32(2):107897
|
|
| S2514 |
Tobramycin
|
Tobramycin (NSC 180514,Deoxykanamycin B, Nebramycin Factor 6) is an aminoglycoside antibiotic with an IC50 of 9.7 μM.
|
-
Oncotarget, 2018, 9(40):26086-26095
|
|
| S3496 |
Lefamulin acetate (Xenleta)
|
Lefamulin acetate (Xenleta, BC-3781 acetate) is a pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP) treatment. It inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of transfer RNA for peptide transfer.
|
-
J Biol Chem, 2022, 298(5):101909
|
|
| E4867 |
Omadacycline
|
Omadacycline(Amadacycline) is an oral aminomethylcycline antibacterial antibiotic used to treat moderate-to-severe infections, such as community-acquired pneumonia and acute bacterial skin and skin structure infections caused by susceptible organisms. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This compound has broad-spectrum antibacterial activity and is effective against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria.
|
|
|